Case File №
#VI-2026-0212
Bfflink
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
37 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | B Good | 13 | 8.1 | 5.8 | 10.0 | 16 Dec 2025 |
| ACE-031 | X N/A | 1 | 9.2 | 9.2 | 9.2 | 3 Jul 2025 |
| Aromasin (Exemestane) | X N/A | 1 | 10.0 | 10.0 | 10.0 | 27 Feb 2025 |
| BMK methyl glycidate CAS 80532-66-7 | X N/A | 1 | 8.6 | 8.6 | 8.6 | 21 May 2025 |
| Botulinum toxin | X N/A | 1 | 5.2 | 5.2 | 5.2 | 24 Apr 2025 |
| BPC157 10mg + TB500 10mg Blend | X N/A | 1 | 9.2 | 9.2 | 9.2 | 16 Mar 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 10.0 | 10.0 | 10.0 | 13 Feb 2025 |
| CJC-1295 With DAC | X N/A | 1 | 7.4 | 7.4 | 7.4 | 3 Jun 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 1 | 8.7 | 8.7 | 8.7 | 21 May 2025 |
| Cortagen | X N/A | 1 | 6.6 | 6.6 | 6.6 | 8 Jul 2025 |
| DHB (1-Test Cyp) Oral | X N/A | 1 | 10.0 | 10.0 | 10.0 | 6 May 2025 |
| DHT (Stanolone) | X N/A | 1 | 9.4 | 9.4 | 9.4 | 27 Feb 2025 |
| EPO | X N/A | 1 | 8.2 | 8.2 | 8.2 | 6 May 2025 |
| Hyaluronic acid | X N/A | 1 | 8.1 | 8.1 | 8.1 | 14 Jan 2025 |
| IGF-1 LR3 | X N/A | 1 | 8.5 | 8.5 | 8.5 | 3 Jul 2025 |
| Ivermectin | X N/A | 1 | 7.9 | 7.9 | 7.9 | 28 Mar 2025 |
| LL37 | X N/A | 1 | 8.3 | 8.3 | 8.3 | 20 Jun 2025 |
| Masteron P (Drostanolone P) | X N/A | 1 | 8.4 | 8.4 | 8.4 | 11 Jun 2025 |
| Methylstenbolone | X N/A | 1 | 7.1 | 7.1 | 7.1 | 17 Dec 2024 |
| Minoxidil Oral | X N/A | 1 | 8.3 | 8.3 | 8.3 | 21 May 2025 |
| MT-1 | X N/A | 1 | 6.8 | 6.8 | 6.8 | 28 Mar 2025 |
| N-Acetyl Epitalon Amidate | X N/A | 1 | 6.8 | 6.8 | 6.8 | 2 Apr 2025 |
| NA Semax Amidate | X N/A | 1 | 7.8 | 7.8 | 7.8 | 27 Feb 2025 |
| NandroMix 300 | X N/A | 1 | 8.1 | 8.1 | 8.1 | 21 May 2025 |
| Oxymetholone (Anadrol) Raw | X N/A | 1 | 6.4 | 6.4 | 6.4 | 25 Apr 2025 |
| PEG MGF | X N/A | 1 | 7.7 | 7.7 | 7.7 | 13 Feb 2025 |
| PTD-DBM | X N/A | 1 | 6.7 | 6.7 | 6.7 | 11 Jun 2025 |
| Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) | X N/A | 1 | 8.1 | 8.1 | 8.1 | 21 May 2025 |
| Selank | X N/A | 1 | 8.3 | 8.3 | 8.3 | 3 Jul 2025 |
| Semax | X N/A | 1 | 7.2 | 7.2 | 7.2 | 25 Apr 2025 |
| SLU-PP-332 250mcg + BAM15 50mcg Blend | X N/A | 1 | 8.7 | 8.7 | 8.7 | 20 Jun 2025 |
| SR9009 | X N/A | 1 | 6.3 | 6.3 | 6.3 | 28 Mar 2025 |
| SS-31 (Elamipretide) Raw | X N/A | 1 | 8.6 | 8.6 | 8.6 | 3 Jul 2025 |
| Tadalafil Raw | X N/A | 1 | 7.0 | 7.0 | 7.0 | 16 Mar 2025 |
| Test Base (No Ester) | X N/A | 1 | 9.7 | 9.7 | 9.7 | 8 Jul 2025 |
| Vesugen | X N/A | 1 | 9.2 | 9.2 | 9.2 | 2 Jul 2025 |
| Winstrol Oil | X N/A | 1 | 8.1 | 8.1 | 8.1 | 14 Jan 2025 |
Exhibit II
Evidence Log
43 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | IGF-1 LR3 | 8.8 A | 30mg | 27.6mg | -7.9% | 99.81% | zz46nk | Lab A | Community |
| 24 May 2026 | Masteron P (Drostanolone P) | 10.0 A | 250mg/ml | 296.1mg/ml | +18.4% | 95.88% | ahhm4i | Lab F | Public |
| 24 May 2026 | Retatrutide | 9.4 A | 30mg | 29.1mg | -3.0% | 99.65% | n/a | No Label / Silver Crimp / Blue Cap | Lab E |
| 24 May 2026 | Retatrutide | 10.0 A | 20mg | 19.6mg | -2.0% | 99.90% | n/a | No Label / Silver Crimp / Blue Cap | Lab E |
| 24 May 2026 | NA Semax Amidate | 8.3 A | 5mg | 6.2mg | +24.8% | 98.45% | qkwb4g | Lab C | Public |
| 24 May 2026 | BPC157 10mg + TB500 10mg Blend | 9.6 A | 2mg | 2.2mg | +10.9% | 97.86% | dr9rfi | Lab B | Public |
| 24 May 2026 | Methylstenbolone | 7.4 A | 50mg | 54.6mg | +9.2% | 97.27% | sbdxgj | Lab F | Public |
| 23 May 2026 | Retatrutide | 6.4 B | 60mg | 53.4mg | -11.0% | 99.09% | n/a | (no data) | Lab E |
| 23 May 2026 | CJC-1295 With DAC | 7.1 A | 5mg | 4.3mg | -14.3% | 97.76% | h5v97t | Lab A | Community |
| 22 May 2026 | Retatrutide | 9.2 A | 60mg | 64.4mg | +7.3% | 99.90% | below LOQ | No Label / Silver Crimp / Blue Cap | Lab E |
| 22 May 2026 | Retatrutide | 7.3 A | 20mg | 21.3mg | +6.5% | 99.81% | n/a | No Label / Silver Crimp / Blue Cap | Lab E |
| 22 May 2026 | Retatrutide | 8.7 A | 30mg | 28.6mg | -4.7% | 99.37% | n/a | White Label / Silver Crimp / Blue Cap | Lab E |
| 21 May 2026 | Retatrutide | 7.8 A | 5mg | 4.45mg | -11.0% | 99.73% | n/a | White Label / Silver Crimp / Blue Cap | Lab E |
| 20 May 2026 | BMK methyl glycidate CAS 80532-66-7 | 9.5 A | 1g | 1.2g | +15.4% | 98.92% | fiadop | Lab C | Public |
| 20 May 2026 | Semax | 7.9 A | 10mg | 10.3mg | +2.8% | 96.63% | 9xk3qu | Lab G | Public |
| 19 May 2026 | BPC157 5mg + TB500 5mg Blend | 9.0 A | 10mg | 9.8mg | -2.2% | 95.04% | pbcc89 | Lab G | Community |
| 19 May 2026 | Vesugen | 9.5 A | 50mg | 57.5mg | +15.0% | 96.78% | 2kli9r | Lab G | Community |
| 17 May 2026 | DHB (1-Test Cyp) Oral | 9.8 A | 100mg | 103.8mg | +3.8% | 95.62% | iyw7qs | Lab G | Public |
| 17 May 2026 | DHT (Stanolone) | 8.5 A | 300mg/ml | 361.7mg/ml | +20.6% | 97.76% | i7wipr | Lab D | Community |
| 17 May 2026 | Selank | 8.9 A | 10mg | 9.8mg | -2.0% | 97.54% | vqnag1 | Lab G | Public |
| 26 Jan 2026 | Aromasin (Exemestane) | 8.5 A | 10mg | 10.3mg | +2.5% | 99.94% | mxaglz | Lab E | Public |
| 26 Jan 2026 | EPO | 9.1 A | 20mg | 20.1mg | +0.6% | 99.45% | ytq2h6 | Lab C | Public |
| 26 Jan 2026 | Minoxidil Oral | 7.6 A | 20mg | 20.0mg | -0.1% | 97.03% | 7k1qlu | Lab E | Community |
| 26 Jan 2026 | PEG MGF | 9.5 A | 50mg | 55.5mg | +11.1% | 97.06% | otnrpg | Lab A | Community |
| 9 Jan 2026 | Ivermectin | 5.6 B | 10mg | 10.6mg | +6.5% | 97.68% | 3tb4xr | Lab C | Public |
| 9 Jan 2026 | SR9009 | 5.8 B | 10mg | 11.7mg | +17.4% | 98.32% | qf24ta | Lab C | Community |
| 7 Jan 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 6.6 A | 20mg | 24.0mg | +19.8% | 96.44% | bbif47 | Lab E | Public |
| 6 Jan 2026 | N-Acetyl Epitalon Amidate | 8.3 A | 5mg | 6.1mg | +22.3% | 98.29% | h5p55f | Lab F | Public |
| 29 Dec 2025 | Hyaluronic acid | 7.5 A | 50mg | 55.1mg | +10.3% | 95.54% | 99697j | Lab D | Community |
| 12 Dec 2025 | NandroMix 300 | 7.4 A | 200mg/ml | 174.0mg/ml | -13.0% | 98.83% | vjaqx5 | Lab E | Public |
| 12 Dec 2025 | SS-31 (Elamipretide) Raw | 10.0 A | 1g | 0.9g | -13.4% | 96.22% | nbo1f4 | Lab E | Public |
| 12 Dec 2025 | Test Base (No Ester) | 10.0 A | 300mg/ml | 306.0mg/ml | +2.0% | 99.41% | bgvefy | Lab A | Public |
| 12 Dec 2025 | Winstrol Oil | 7.4 A | 300mg/ml | 319.6mg/ml | +6.5% | 95.93% | m6fxgk | Lab B | Public |
| 5 Dec 2025 | Oxymetholone (Anadrol) Raw | 6.3 A | 10g | 11.5g | +14.7% | 97.05% | k8u64l | Lab B | Public |
| 17 Nov 2025 | Cortagen | 6.2 A | 2mg | 1.9mg | -5.5% | 97.57% | qc736n | Lab F | Public |
| 17 Nov 2025 | PTD-DBM | 6.2 A | 5mg | 5.6mg | +11.7% | 96.46% | gi6q5g | Lab D | Public |
| 17 Nov 2025 | Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) | 6.2 A | 100mg/ml | 110.8mg/ml | +10.8% | 97.13% | setf25 | Lab F | Community |
| 14 Nov 2025 | LL37 | 7.0 A | 30mg | 32.9mg | +9.8% | 97.94% | 3su6j3 | Lab D | Public |
| 14 Nov 2025 | SLU-PP-332 250mcg + BAM15 50mcg Blend | 8.9 A | 20mg | 18.9mg | -5.4% | 99.37% | 4bgd7h | Lab A | Public |
| 14 Nov 2025 | Tadalafil Raw | 5.9 B | 1g | 1.0g | -1.1% | 96.71% | nypqr1 | Lab D | Public |
| 17 Oct 2025 | ACE-031 | 10.0 A | 2mg | 1.8mg | -10.1% | 98.25% | 0z4nv5 | Lab A | Community |
| 17 Oct 2025 | Botulinum toxin | 4.2 C | 5mg | 4.8mg | -3.1% | 96.44% | kzlqdh | Lab F | Public |
| 3 Oct 2025 | MT-1 | 7.5 A | 30mg | 26.5mg | -11.8% | 95.51% | akhlxw | Lab B | Community |
— END OF EVIDENCE LOG —